全文获取类型
收费全文 | 246450篇 |
免费 | 19656篇 |
国内免费 | 5867篇 |
专业分类
耳鼻咽喉 | 1763篇 |
儿科学 | 4539篇 |
妇产科学 | 4678篇 |
基础医学 | 28995篇 |
口腔科学 | 5090篇 |
临床医学 | 20608篇 |
内科学 | 36612篇 |
皮肤病学 | 2890篇 |
神经病学 | 13747篇 |
特种医学 | 7666篇 |
外国民族医学 | 13篇 |
外科学 | 18801篇 |
综合类 | 34237篇 |
现状与发展 | 31篇 |
一般理论 | 8篇 |
预防医学 | 24143篇 |
眼科学 | 2666篇 |
药学 | 32837篇 |
100篇 | |
中国医学 | 14842篇 |
肿瘤学 | 17707篇 |
出版年
2024年 | 224篇 |
2023年 | 3438篇 |
2022年 | 5093篇 |
2021年 | 10351篇 |
2020年 | 9147篇 |
2019年 | 8967篇 |
2018年 | 9082篇 |
2017年 | 9247篇 |
2016年 | 9496篇 |
2015年 | 9177篇 |
2014年 | 12109篇 |
2013年 | 16612篇 |
2012年 | 13705篇 |
2011年 | 15846篇 |
2010年 | 10724篇 |
2009年 | 10562篇 |
2008年 | 12096篇 |
2007年 | 13008篇 |
2006年 | 11828篇 |
2005年 | 10800篇 |
2004年 | 9176篇 |
2003年 | 7955篇 |
2002年 | 6178篇 |
2001年 | 5633篇 |
2000年 | 4631篇 |
1999年 | 3922篇 |
1998年 | 2910篇 |
1997年 | 2967篇 |
1996年 | 2700篇 |
1995年 | 2502篇 |
1994年 | 2422篇 |
1993年 | 1995篇 |
1992年 | 1859篇 |
1991年 | 1725篇 |
1990年 | 1464篇 |
1989年 | 1219篇 |
1988年 | 1122篇 |
1987年 | 1052篇 |
1986年 | 936篇 |
1985年 | 1383篇 |
1984年 | 1115篇 |
1983年 | 821篇 |
1982年 | 874篇 |
1981年 | 711篇 |
1980年 | 677篇 |
1979年 | 541篇 |
1978年 | 349篇 |
1977年 | 313篇 |
1976年 | 291篇 |
1975年 | 215篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
目的研究生慧汤对APP/PS1(β-amyloid precursor protein/presenilin 1246E)小鼠海马内β淀粉样前体蛋白(Amyloid precursor protein,APP)代谢产物昼夜表达的影响。方法 将56只雄性APP/PS1双转基因痴呆模型小鼠随机分为4组,分别为:痴呆模型组、褪黑素治疗组(0.78 mg·kg-1·d-1)、生慧汤高剂量组(27.0 g·kg-1·d-1)、生慧汤低剂量组(13.5 g·kg-1·d-1),每组14只;对照组为14只雄性C57BL/6J小鼠,连续给药30天。采用Morris水迷宫检测小鼠学习记忆能力,采用酶联免疫吸附检测(ELISA)检测不同时间段取出的海马组织sAPPα含量。对海马β淀粉样蛋白1-40、β淀粉样蛋白1-42表达进行免疫印迹分析。免疫组化(IHC)检测海马CA1区Aβ1-40蛋白的表达。结果 Morris水迷宫结果表明,与对照组相比,模型组上平台潜伏期明显延长、穿越平台次数明显减少(P<0.01);与模型组相比,生慧汤不同剂量组上平台潜伏期明显缩短(P<0.01、P<0.05),穿越平台次数明显增加(P<0.05)。ELISA结果表明,与对照组相比,模型组的sAPPα总量、各时间段(12:00、24:00)sAPPα含量明显减少(P<0.01);与模型组相比,生慧汤不同剂量组sAPPα总量明显增多(P<0.01、P<0.05),生慧汤高剂量组仅能增加12:00 sAPPα含量(P<0.01),生慧汤低剂量组仅能增加24:00 sAPPα含量(P<0.05)。对照组sAPPα含量具有明显昼夜差异(P<0.01)。模型组sAPPα含量的昼夜差异性消失(P>0.05)。生慧汤高剂量组sAPPα含量具有昼夜差异(P<0.01),生慧汤低剂量组sAPPα含量不具有昼夜差异(P>0.05)。Western blot结果显示,与对照组相比,模型组Aβ1-40、Aβ1-42蛋白表达明显增加(P<0.01);与模型组相比,生慧汤高剂量组Aβ1-40、Aβ1-42蛋白表达减少(P<0.05、P<0.01);生慧汤低剂量组仅能减少Aβ1-40蛋白的表达(P<0.05),对Aβ1-42蛋白表达无影响(P>0.05)。免疫组化结果表明,与对照组相比,模型组Aβ1-40表达明显增加(P<0.01);与模型组相比,生慧汤不同剂量组Aβ1-40表达不同程度减少(P<0.01、P<0.05)。结论 生慧汤能够改善5月龄APP/PS1阿尔茨海默病模型小鼠的学习记忆障碍,其机制可能与恢复海马内APP代谢产物sAPPα的昼夜节律性表达、从而减少Aβ的沉积有关。 相似文献
102.
103.
Mariano E. Menendez Suleiman Y. Sudah Patrick J. Denard 《Seminars in Arthroplasty》2022,32(3):644-649
BackgroundThe growing enthusiasm for the use of reverse shoulder arthroplasty (RSA) in the treatment of primary glenohumeral osteoarthritis (GHOA) with an intact rotator cuff is based on data derived from single-center studies with limited generalizability and follow-up. This study compared patient-reported outcomes (PROs) between RSA and total shoulder arthroplasty (TSA) for the treatment of primary GHOA with up to 5-year follow-up and examined temporal trends in the treatment of GHOA between 2012 and 2021.MethodsA retrospective review was performed on patients with primary GHOA undergoing primary arthroplasty surgery from the Surgical Outcomes System global registry between 2012 and 2021. PROs including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE) score, and visual analog scale (VAS) for pain were compared between RSA and TSA at 1, 2, and 5 years postoperatively.ResultsA total of 4451 patients were included, with 2693 (60.5%) undergoing TSA and 1758 (39.5%) undergoing RSA. Both RSA and TSA provided clinically excellent outcomes at 1 year postoperatively (ASES: 80.8 ± 17.9 vs. 85.9 ± 15.2, respectively; SANE: 74.8 ± 24.7 vs. 79.5 ± 22.9; VAS pain: 1.3 ± 2.0 vs. 1.1 ± 1.7; all P < .05) that were maintained at 2 years (ASES: 81.3 ± 19.3 vs. 87.3 ± 14.9; SANE: 74.8 ± 26.2 vs. 79.7 ± 24.7; VAS pain: 1.3 ± 2.1 vs. 1.0 ± 1.6; all P < .05) and 5 years (ASES: 81.7 ± 16.5 vs. 86.9 ± 15.3; SANE: 71.6 ± 28.5 vs. 78.2 ± 25.9; VAS pain: 1.0 ± 1.7 vs. 1.0 ± 1.7; all P < .05), with statistical significance favoring TSA. After controlling for age and sex, there was an adjusted difference of 4.5 units in the ASES score favoring TSA (P = .005) at 5 years postoperatively but no differences in adjusted SANE (P = .745) and VAS pain (P = .332) scores. The use of RSA for GHOA grew considerably over time, from representing only 17% of all replacements performed for GHOA in 2012 to nearly half (47%) in 2021 (P < .001).ConclusionRSA as a treatment for GHOA with an intact rotator cuff seems to yield PROs that are largely clinically equivalent to TSA extending to 5 years postoperatively. The observed statistical significance favoring TSA appears to be of marginal clinical benefit based on established minimal clinically important differences and may be a result of the large sample size. Further research using more granular clinical data and examining differences in range of motion and complications is warranted as it may change the value analysis. 相似文献
104.
昆虫抗菌肽是昆虫为抵御外界病原微生物感染产生的免疫活性物质的总称,其优异的抗炎活性使其具有广阔的应用前景。综述了不同种类昆虫抗菌肽的抗炎活性及可能涉及的信号通路,介绍了昆虫抗菌肽临床研究现状,以期为昆虫抗菌肽的应用研究提供文献参考。 相似文献
105.
Bacterial keratitis continues to be one of the leading causes of corneal blindness in the developed as well as the developing world, despite swift progress since the dawn of the “anti-biotic era”. Although, we have expeditiously developed our understanding about the different causative organisms and associated pathology leading to keratitis, extensive gaps in knowledge continue to dampen the efforts required for early and accurate diagnosis, and management in these patients, resulting in poor clinical outcomes. The ability of the causative bacteria to subdue the therapeutic challenge stems from their large genome encoding complex regulatory networks, variety of unique virulence factors, and rapid secretion of tissue damaging proteases and toxins.In this review article, we provide an overview of the established diagnostic techniques and therapeutics for keratitis caused by various bacteria. We extensively report the recent in-roads through novel tools for accurately diagnosing mono- and poly-bacterial corneal infections. Furthermore, we outline the recent progress by our groups and others in understanding the sub-cellular genomic changes that lead to antibiotic resistance in these organisms. Finally, we discuss in detail, the novel therapies and drug delivery systems in development for the efficacious management of bacterial keratitis. 相似文献
106.
107.
108.
目的运用网络药理学方法预测黄连解毒汤抗Hp感染的主要有效成分、靶点及信号通路,挖掘其潜在作用机制,为后续实验研究提供依据。方法应用TCMSP筛选黄连解毒汤中黄连、黄芩、黄柏、栀子4味中药的主要有效成分及其潜在作用靶点。通过GeneCards数据库和人类孟德尔遗传数据库(OMIM)筛选Hp感染相关靶点,并取药物和疾病的交集靶点。将交集靶点导入Cytoscape 3.7.2构建有效成分和Hp感染相关靶点网络,并进行拓扑学分析。应用STRING在线分析平台构建靶蛋白相互作用(PPI)网络并进行分析。运用R语言在线检索Bioconductor平台对靶点进行GO功能富集;通过DAVID数据库对靶点进行KEGG通路富集分析。结果黄连解毒汤中共筛选出85个有效成分,主要包括槲皮素、小檗碱、山柰酚、汉黄芩素、黄芩素等。对应靶点112个,疾病相关靶点1960个,药物疾病共同靶点71个。网络中度值最高的有效成分为槲皮素,度值最高的靶点为环加氧酶1(PTGS1)。PPI网络中69个节点中度值较高的靶蛋白包括半胱氨酸蛋白酶3(CASP3)、IL6、MAPK8、原癌基因(MYC)、VEGFA、表皮生长因子受体(EGFR)等。GO功能富集分析共获得89个条目,KEGG通路富集分析共筛选12条存在显著差异的信号通路,其中发挥主要作用的有癌症通路、ErbB信号通路、p53信号通路、凋亡、黏附斑等。结论黄连解毒汤可通过多成分、多靶点、多通路发挥对Hp的治疗作用,可通过抗肿瘤机制调控胃癌进程,本研究可为其有效成分研究和抗Hp机制研究提供依据。 相似文献
109.
This study evaluated the genetic variation of 17 autosomal short tandem repeat (STR) loci included in the PowerPlex® 18D Kit. Samples of 562 unrelated healthy Lahu individuals living in Yunnan Province in southwestern China were investigated. The data were analyzed to provide information on allele frequencies and other statistical parameters relevant to the forensic population. Of the 17 loci, 16 reached the Hardy–Weinberg equilibrium after Bonferroni correction. A total of 176 alleles were identified in 17 STR loci, and allele frequencies ranged from 0.000 890 to 0.578 292. The combined discrimination power (CPD) and probability of excluding paternity (CPE) of the 17 STR loci were 0.999 999 999 999 999 999 489 and 0.999 998 301 753 122. The genetic relationships among 28 populations were also estimated. 相似文献
110.
《The Journal of thoracic and cardiovascular surgery》2023,165(2):750-760.e5
ObjectivesThe reduction of postoperative acute kidney injury in patients undergoing cardiopulmonary bypass surgery using an oxygen delivery-guided perfusion strategy (oxygen delivery strategy) for cardiopulmonary bypass management compared with a fixed flow perfusion (conventional strategy) remains controversial. The purpose of this study was to determine whether a oxygen delivery strategy would reduce the incidence of postoperative acute kidney injury in patients undergoing cardiopulmonary bypass surgery.MethodsWe randomly enrolled 300 patients undergoing cardiopulmonary bypass surgery. Patients were randomly assigned to a oxygen delivery strategy (maintaining a oxygen delivery index value >300 mL/min/m2 through pump flow adjustments during cardiopulmonary bypass) or a conventional strategy (a target pump flow was determined on the basis of the body surface area). The primary end point was the development of acute kidney injury. Secondary end points were the red blood cell transfusion rate and number of red blood cell units, intubation time, postoperative length of stay in the intensive care unit and the hospital, predischarge estimated glomerular filtration rate, and hospital mortality.ResultsAcute kidney injury occurred in 20 patients (14.6%) receiving the oxygen delivery strategy and in 42 patients (30.4%) receiving the conventional strategy (relative risk, 0.48; 95% confidence interval, 0.30-0.77; P = .002). The secondary end points were not significantly different between strategies. In a prespecified subgroup analysis of patients who had nadir hematocrit less than 23% or body surface area less than 1.40 m2, the oxygen delivery strategy seemed to be superior to the conventional strategy and the existence of quantitative interactions was suggested.ConclusionsAn oxygen delivery strategy for cardiopulmonary bypass management was superior to a conventional strategy with respect to preventing the development of acute kidney injury. 相似文献